eLife (Apr 2019)

Transcriptional down-regulation of ccr5 in a subset of HIV+ controllers and their family members

  • Elena Gonzalo-Gil,
  • Patrick B Rapuano,
  • Uchenna Ikediobi,
  • Rebecca Leibowitz,
  • Sameet Mehta,
  • Ayse K Coskun,
  • J Zachary Porterfield,
  • Teagan D Lampkin,
  • Vincent C Marconi,
  • David Rimland,
  • Bruce D Walker,
  • Steven Deeks,
  • Richard E Sutton

DOI
https://doi.org/10.7554/eLife.44360
Journal volume & issue
Vol. 8

Abstract

Read online

HIV +Elite and Viremic controllers (EC/VCs) are able to control virus infection, perhaps because of host genetic determinants. We identified 16% (21 of 131) EC/VCs with CD4 +T cells with resistance specific to R5-tropic HIV, reversed after introduction of ccr5. R5 resistance was not observed in macrophages and depended upon the method of T cell activation. CD4 +T cells of these EC/VCs had lower ccr2 and ccr5 RNA levels, reduced CCR2 and CCR5 cell-surface expression, and decreased levels of secreted chemokines. T cells had no changes in chemokine receptor mRNA half-life but instead had lower levels of active transcription of ccr2 and ccr5, despite having more accessible chromatin by ATAC-seq. Other nearby genes were also down-regulated, over a region of ~500 kb on chromosome 3p21. This same R5 resistance phenotype was observed in family members of an index VC, also associated with ccr2/ccr5 down-regulation, suggesting that the phenotype is heritable.

Keywords